Six documents that take your complaint handling program from ad-hoc to audit-ready — covering intake, MDR reportability, investigation, trending, and CAPA escalation.
For QA managers and RA leads at medical device companies.
FDA investigators don't expect zero complaints. They expect documented MDR reportability decisions, consistent investigation records, and a clear escalation path to CAPA. When those records don't exist — or contradict each other — 483s turn into warning letters.
Most QA teams write complaint procedures once and never update the MDR decision logic as regulations evolve. This toolkit gives you current, auditable documentation that answers every question an investigator will ask.
From intake through MDR reporting through CAPA escalation.
21 CFR 820.198 and ISO 13485 §8.2.2 compliant procedure covering complaint intake, evaluation criteria, investigation requirements, and regulatory reporting thresholds. Includes complaint definition decision matrix and required record fields.
Step-by-step decision logic for MDR reportability: malfunction, serious injury, and death reporting thresholds. Covers 30-day, 5-day, and MDR Supplement timelines with device manufacturer and distributor obligations mapped.
Structured investigation form covering complaint description, device identification, patient impact assessment, root cause analysis fields, and resolution documentation. Paired with a complaint log template for trending and regulatory tracking.
Scenario-based matrix mapping complaint types to reportability determinations under 21 CFR Part 803. Covers device malfunction, serious injury, and death scenarios with not-reportable justification fields and FDA eMDR submission notes.
Structured annual review template for MDR trend analysis, complaint rate benchmarking, and signal detection. Aligns with FDA postmarket surveillance expectations and ISO 13485 §8.2.2 requirements for management review input.
Standard operating procedure defining escalation criteria from complaint investigation to CAPA initiation. Covers severity scoring, trending thresholds, CAPA linkage fields, and quality management system integration under 21 CFR 820.100.
Every template maps to FDA complaint handling requirements under Part 820 and ISO 13485 section 8.2.2. One set of documents works for FDA QSR and international audits.
The decision tree and reportability matrix eliminate the ambiguity that causes teams to spend hours on each complaint determination. Documented logic protects you during inspection.
The escalation SOP defines exactly when a complaint triggers CAPA — the #1 gap FDA investigators find. Trending criteria and severity scoring are pre-built.
Stripe checkout. Instant download after payment. 7-day money-back guarantee.
“We had an FDA inspection six months after implementing this complaint procedure. The investigator asked to see our MDR reportability determinations — we handed over the matrix with documented rationale for every complaint. Zero 483 observations on complaint handling.”
“Our complaint handling was scattered across three systems with no consistent escalation criteria. This toolkit gave us a single complaint-to-CAPA workflow that our whole QA team now follows. The investigation form alone saved us hours per complaint.”
“The MDR decision tree is exactly what our team needed. We were manually interpreting 21 CFR Part 803 for every serious complaint — now we have documented decision logic with reportability justification built into the form. Notified body loved it.”
RegWatchDaily tracks FDA guidance, 483 trends, and MDR reportability updates. Free newsletter for QA/RA professionals.
$247 · Instant download · 7-day money-back guarantee